Personal information

No personal information available

Activities

Collapse all

Employment (3)

Södersjukhuset: Stockholm, SE

(Specialist Care)
Employment
Source: check_circle
Karolinska Institutet

Karolinska Institutet: Stockholm, SE

(Department of Oncology-Pathology)
Employment
Source: check_circle
Karolinska Institutet

Region Stockholm: Stockholm, SE

2020-05-18 to present | Oncologist (Department of Oncology, Södersjukhuset.)
Employment
Source: Self-asserted source
Anders Lideståhl

Education and qualifications (1)

Umeå University: Umeå, SE

1994 to 2001 | M.D.
Education
Source: Self-asserted source
Anders Lideståhl

Works (7)

Changes on myocardial perfusion scintigraphy and contrast-enhanced cardiac magnetic resonance imaging after definitive radiotherapy in patients with lung cancer

Journal of Radiotherapy in Practice
2022-12 | Journal article
DOI: 10.1017/S1460396921000091
Contributors: A. Lideståhl; T. Larsson; L. Thorén; O. Brodin; P. A. Lind
Source: check_circle
Crossref

An in silico planning study comparing doses and estimated risk of toxicity in 3D-CRT, IMRT and proton beam therapy of patients with thymic tumours

Phys Med
2019 | Journal article
DOI: 10.1016/j.ejmp.2019.03.028
SOURCE-WORK-ID:

140717206

PMID: 31000071
Contributors: Lideståhl, A; Mondlane, G; Gubanski, M; Lind, PA; Siegbahn, A
Source: check_circle
Karolinska Institutet

Quantitative assessment of lung density changes after 3-D radiotherapy for breast cancer

Acta Oncol
2007 | Journal article
DOI: 10.1080/02841860600949586
SOURCE-WORK-ID:

12539990

PMID: 17453367
Contributors: Blom-Goldman, U; Svane, G; Wennberg, B; Lideståhl, A; Lind, PA
Source: check_circle
Karolinska Institutet

Efficacy of systemic therapy in advanced pancreatic carcinoma

Acta Oncol
2006 | Journal article
DOI: 10.1080/02841860500537861
SOURCE-WORK-ID:

1954362

PMID: 16546858
Contributors: Lideståhl, A; Permert, J; Linder, S; Bylund, H; Edsborg, N; Lind, P
Source: check_circle
Karolinska Institutet

Reassessment for radical surgery after palliative chemotherapy in locally advanced pancreatic carcinoma: Two case-reports

Acta Oncol.
2006 | Journal article
DOI: 10.1080/02841860500537572
SOURCE-WORK-ID:

111863782

PMID: 16546868
Contributors: Lidestahl, A; Permert, J; Linder, S; Bylund, H; Edsborg, N; Lind, P
Source: check_circle
Karolinska Institutet

ROC curves and evaluation of radiation-induced pulmonary toxicity in breast cancer

Int J Radiat Oncol Biol Phys
2006 | Journal article
DOI: 10.1016/j.ijrobp.2005.08.011
SOURCE-WORK-ID:

1932511

PMID: 16257129
Contributors: Lind, PA; Wennberg, B; Gagliardi, G; Rosfors, S; Blom-Goldman, U; Lideståhl, A; Svane, G
Source: check_circle
Karolinska Institutet

Capecitabine as third line therapy in patients with advanced colorectal cancer

Acta Oncol
2005 | Journal article
DOI: 10.1080/02841860510029662
SOURCE-WORK-ID:

1955376

PMID: 16076695
Contributors: Gubanski, M; Naucler, G; Almerud, A; Lideståhl, A; Lind, PA
Source: check_circle
Karolinska Institutet
How many people are using ORCID?